News

Technology News

Covidien Launches First Approved Spine Sealant

Thursday, November 12, 2009 5:03:00 AM PDT | VentureDeal Staff

North Haven, Connecticut  --  Medical device company Covidien (NYSE: COV) announced the launch of what it calls the first FDA approved spine sealant.

The purpose of the sealant, called DuraSeal, is for intra-operative sealing of the dural membrane during spinal operations.

The company cited a clinical study of more than 150 patients, where the spine sealant was shown to be a superior sealing agent when compared to other closure techniques such as sutures or fibrin sealants.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.